在PDAC中CRISPR/Cas9基因组工程:从临床前研究到翻译和临床研究
Yanxi Lu1, Jojanneke Stoof2, Yaba Rosette Tanoé3
1Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen 91054, Germany.
Seminars in cancer biology
|July 12, 2025
概括
CRISPR/Cas9基因编辑通过使先进的遗传研究和模型开发成为可能,彻底改变了胰腺癌研究. 这项技术还提高了癌症治疗的CAR-T细胞治疗精度.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 胰腺管腺癌 (PDAC) 提出了重大研究挑战.
- 克里斯普尔/Cas9技术为研究PDAC提供了新的方法.
- 了解PDAC中的基因功能对于治疗开发至关重要.
研究的目的:
- 审查CRISPR技术在PDAC研究中的演变和应用.
- 检查CRISPR在PDAC的同位素和小鼠模型中的实用性.
- 探索CRISPR在了解免疫-瘤相互作用和CAR-T细胞治疗中的作用.
主要方法:
- 审查CRISPR/Cas9编辑技术和选方法.
- 在同位素和基因工程小鼠模型 (GEMMs) 中分析CRISPR应用.
- 探索CRISPR屏幕的免疫-瘤细胞相互作用和CAR-T细胞诊断.
主要成果:
- 克里斯普尔/Cas9促进了对PDAC通路,扩散,迁移,入侵和化学抵抗中的基因的深入研究.
- 基于CRISPR的模型增强了PDAC的研究能力.
- 克里斯普尔屏幕揭示了重要的免疫-瘤细胞相互作用.
- 克里斯普尔/Cas9提高了CAR-T细胞治疗的向性,并减少了非瘤效应.
结论:
- 克里斯普尔/Cas9是一种多功能工具,可以改变PDAC研究和治疗策略.
- 该技术有助于开发先进的PDAC模型和理解复杂的生物过程.
- 克里斯普尔/Cas9对精确瘤学作出了重大贡献,特别是在CAR-T细胞治疗的开发中.
相关概念视频
01:28CRISPR/Cas9 Genome Editing
272
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
272
01:59CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
02:53CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K